VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1673930
Sex: F
Age:
State: OH

Vax Date: 04/06/2021
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: tremors; heart was fluttering a lot; palpitations/heart was fluttering a lot; headache; stiff neck; neck pain; GI distress; temperature up and down; jittery; Hot and cold flashes; confusion; Swelling and chills; Swelling and chills; muscle got really tightened, couldn't move around things; This is a spontaneous report from a contactable consumer (patient). This 48-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0150) via an unspecified route of administration 06Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, fibromyalgia, tremors and movement disorder issues. Concomitant medications included medical marijuana and albuterol from unknown dates for unknown indications. On unspecified dates the patient experienced a little palpitations/heart was fluttering a lot, swelling, chills, headache, stiff neck, tremors, neck pain, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, hot and cold flashes, and some confusion. Somebody had mentioned to the patient anaphylactic shock but she never had an anaphylactic shock. The neck pain was going on for about a week. It was subsiding slightly. The confusion seemed to also had subsided from the last 2 days or so (as of 19Apr2021). The tremors were the primary issue the patient was having. The patient was going to visit a neurophysiologist as a result of the events before the second dose of BNT162B2 to make sure it was safe. The patient received treatment with aspirin and then low dose aspirin, a vitamin, bismuth salicylate (PEPTOBISMOL) for GI distress, and medical marijuana. The outcome of tremors was not recovered. The outcomes of neck pain and confusion were recovering. The outcomes of palpitations, swelling, chills, headache, stiff neck, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, and hot and cold flashes were unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: MARIJUANA; ALBUTEROL SULFATE

Current Illness:

ID: 1673931
Sex: M
Age:
State: AZ

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: General, mild, flu-like symptoms; Headache; Brain fog; Muscle aches; Skin sensitivity; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 06:00, the patient experienced general, mild, flu-like symptoms the day following the injection. The patient also experienced headache, brain fog, muscle aches, skin sensitivity and mild fever. Appetite and digestion seemed to be normal. On day two, symptoms seemed to be declined quickly, saved for a bit of brain fog. Largely as he might have expected, just reporting it to assist with data collection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events general, mild, flu-like symptoms, headache, brain fog, muscle aches, skin sensitivity and mild fever were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673932
Sex: F
Age:
State: GA

Vax Date: 04/13/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Intense neck pain; Overall aches; Low fever; Painful sore throat/ears; Painful sore throat/ears; Injection site is still painful and red; Injection site is still painful and red; Injection site is still painful and red w/large sub-dermal knot; Sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included cutaneous lupus and Sjogren's syndrome. The patient was allergic to nickel. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL), ascorbic acid (VITAMIN C), sambucus nigra (ELDERBERRY), melatonin (MANUFACTURER UNKNOWN) and help hair (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 20:00, the patient experienced continuous changes of intense neck pain, overall aches, low fever, painful sore throat/ears and injection site was painful and red with large sub-dermal knot. On an unknown date in Apr2021, the patient experienced sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips). On an unknown date in Apr2021, 1 week later, the events were still present along with the most recent joint pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intense neck pain, overall aches, low fever, painful sore throat, painful sore ears, sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips) and injection site painful and red with large sub-dermal knot were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; VITAMIN C [ASCORBIC ACID]; ELDERBERRY [SAMBUCUS NIGRA]; MELATONIN

Current Illness:

ID: 1673933
Sex: M
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:109 Units:[degF]

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Fever of 101.9F; Muscle aches accompanied the fever but were mostpresent in the first 24 hours.; Soreness in the left arm where vaccine was administered; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 14:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history was not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have any other medications in two weeks. The patient had no known allergies. On 16Apr2021, 16 hours after the vaccination, the patient experienced fever of 101.9 degree Farenheit (degF), which lasted for approximately 48 hours. Also experienced the muscle aches which accompanied the fever but were most present in the first 24 hours and soreness in the left arm where vaccine was administered. On 16Apr2021 at 06:30, 16 hours after the vaccination, the patient underwent lab test which included body temperature and result was 109 (degF). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever of 101.9 (degF), muscle aches and vaccination site soreness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673934
Sex: M
Age:
State: WA

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Localized erythema; Mild induration; Tenderness beyond area of injection approximately 10cm x 7-8 cm starting 2 days after injection; This is a spontaneous report from a contactable physician. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm left on 15Apr2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa drugs. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the arm left on 18Mar2021 at 15:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, 2 days after vaccination, the patient experienced localized erythema, mild induration and tenderness beyond area of injection approximately 10cm x 7-8 cm on vaccinated arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events localized erythema, mild induration, tenderness beyond area of injection approximately 10cm x 7-8 cm starting 2 days after injection were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673935
Sex: F
Age:
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:{DF}; Comments: At 04:00

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Nausea; Vomiting; Severe headaches; Fever 102; This is a spontaneous report from a contactable nurse. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an intramuscular route of administration in the left arm on 21Apr2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included asthma, anxiety and shellfish intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ethinylestradiol; norgestimate (TRI LO MILI) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an intramuscular route of administration in the left arm on 31Mar2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 22Apr2021 at 04:00, the patient experienced nausea, vomiting, severe headaches and fever 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (ADVIL) (200mg) (milligrams) and acetylsalicylic acid (ASPIRIN) (81mg). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, severe headaches and fever 102 (unspecified units) was resolved on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRI LO MILI

Current Illness:

ID: 1673936
Sex: M
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210419; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Dizziness; Weakness; Chills; Fatigue; Swelling of the neck; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0153) via an unspecified route of administration in the left arm on 07Apr2021 at 09:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fish oil (OMEGA 3) and cyanocobalamin (B 12), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced dizziness, weakness, chills, fatigue and swelling of the neck. On an unknown date in Apr2021, two weeks later, the patient experienced vertigo; fatigue and vertigo were present at the time of this report. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if any therapeutic measures were taken as a result of the events. On 19Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the events dizziness, weakness, chills and swelling of the neck were resolved with lasting effects on an unknown date in Apr2021, while fatigue and vertigo were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEGA 3 [FISH OIL]; B 12

Current Illness:

ID: 1673937
Sex: F
Age:
State: FL

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Arm that received shot, and face, are burning as if there's a bad sunburn.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 15:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and mild hypothyroidism. The patient had known allergies to latex, wheat, corn, soy, rice and aspirin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 17:15, the patient experienced arm that received shot, and face, were burning as if there's a bad sunburn. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm that received shot, and face, were burning as if there's a bad sunburn was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673938
Sex: F
Age:
State: TX

Vax Date: 03/27/2021
Onset Date: 04/02/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Developed first time shingles less than a week after second dose; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included morbidly obese, tachycardia, sleep apnea, eosinophilic esophagitis (EoE), chronic migraine, depression, anxiety, seafood allergy (smoked salmon) and allergy to nuts (some nuts). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), propranolol (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN) for unknown indication for unspecified date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 13:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 15:00, the patient developed first time shingles less than a week after second dose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included treatment with antiviral medication and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles less than a week after second dose was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CYMBALTA; WELLBUTRIN; PROPRANOLOL; PANTOPRAZOLE

Current Illness:

ID: 1673939
Sex: F
Age:
State: WI

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Dizziness; face tingling; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 14:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 19Apr2021 at 15:00, the patient experienced dizziness and face tingling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness and face tingling was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673940
Sex: M
Age:
State: CA

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210420; Test Name: Body temperature; Result Unstructured Data: Test Result:102.5 Units:{DF}; Comments: at 20:00

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Grade 2 fatigue; Grade 2 fever with a temperature of 102.5; Grade 2 myalgia; Grade 1 chills; Grade 1 conjunctivitis; Grade 1 edema limbs; Grade 1 injection site reaction; Grade 1 headache; This is a spontaneous report from a contactable physician, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 20Apr2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 30Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 20:00, approximately 10 hours after receiving the second dose of the Pfizer covid vaccine, the patient developed the following symptoms: Grade 2 fatigue, Grade 2 fever with a temperature of 102.5, Grade 2 myalgia, Grade 1 chills, Grade 1 conjunctivitis, Grade 1 edema limbs, Grade 1 injection site reaction and Grade 1 headache. On 20Apr2021 at 20:00, the patient underwent body temperature and the result was 102.5 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Grade 2 fever with a temperature of 102.5 and Grade 1 chills was recovered on an unknown date in Apr2021. The clinical outcome of the events Grade 2 fatigue, Grade 2 myalgia, Grade 1 conjunctivitis, Grade 1 edema limbs, Grade 1 injection site reaction and Grade 1 headache was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673941
Sex: F
Age:
State: WA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 11:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication received within two weeks of vaccination was not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, the patient experienced loss of taste. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event loss of taste was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673942
Sex: F
Age:
State: WI

Vax Date: 04/06/2021
Onset Date: 04/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Tinnitus has gone from very quiet and manageable to very loud.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 00:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included "BP and Thyroid meds" (blood pressure and thyroid medications). The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified BP (blood pressure) and thyroid meds (medications) taken from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 11Apr2021 at 00:00, the patient experienced tinnitus which had gone from very quiet and manageable to very loud. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus had gone from very quiet and manageable to very loud was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness: Blood pressure ("List of any other medications the patient received within 2 weeks of vaccination: BP meds"); Thyroid disorder ("List of any other medications the patient received within 2 weeks of vaccination: thyroid meds")

ID: 1673943
Sex: F
Age:
State: NH

Vax Date: 04/17/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Body Temperature; Result Unstructured Data: Test Result:103.5 Units:{DF}; Comments: temperature jumped up to 103.5 again.; Test Date: 202104; Test Name: Body Temperature; Result Unstructured Data: Test Result:99/100; Comments: had a low-grade fever (99/100) until about 4:30; Test Date: 20210418; Test Name: Body Temperature; Result Unstructured Data: Test Result:101/102; Comments: temperature stayed in the 101/102 range until almost 4am; Test Date: 20210418; Test Name: Body Temperature; Result Unstructured Data: Test Result:104 Units:{DF}; Comments: until about 12:45, where temperature rose to an even 104.; Test Date: 202104; Test Name: Body Temperature; Result Unstructured Data: Test Result:103.5 Units:{DF}; Comments: An hour later (almost midnight), temperature had risen to 103.5; Test Date: 20210417; Test Name: Body Temperature; Result Unstructured Data: Test Result:101.5 Units:{DF}; Comments: 10 hours after injection, with a 101.5 fever

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Started with convulsion-like violent shaking/ was stillshaking until about 12:45; 101.5 fever/ had a low-grade fever (99/100) until about 4:30, when temperature jumped up to 103.5 again.; Temperature had risen to 103.5/ temperature rose to an even 104; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included ethinylestradiol; etonogestrel (NUVARING) from an unknown date for birth control. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 20:45, the patient experienced started with convulsion-like violent shaking about 10 hours after injection, with a 101.5 fever, an hour later on an unknown date in Apr2021, almost midnight; temperature had risen to 103.5 and she was still shaking until about 12:45, where her temperature rose to an even 104. At this point, she called the emergency 24 hours number for her doctor, who advised her to alternate Tylenol and ADVIL every few hours and continued drinking fluids. Temperature stayed in the 101/102 range until almost 4am. The following day, had a low-grade fever (99/100) until about 4:30, when temperature jumped up to 103.5 again. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with over the counter (OTC) medication. On 17Apr2021 at 22:45, the patient underwent Body Temperature and the result was 101.5 (UNSPECIFIED UNITS). On 18Apr2021, the patient underwent Body Temperature and the result was 101/102 (UNSPECIFIED UNITS). On 18Apr2021 at 00:45, the patient underwent Body Temperature and the result was 104 (UNSPECIFIED UNITS). On an unknown date in Apr2021, the patient underwent Body Temperature and the result was 103.5 (UNSPECIFIED UNITS). On an unknown date in Apr2021, the patient underwent Body Temperature and the result was 99/100 (UNSPECIFIED UNITS). On an unknown date in Apr2021, the patient underwent Body Temperature and the result was 103.5 (UNSPECIFIED UNITS). Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events started with convulsion-like violent shaking, with a 101.5 fever, temperature had risen to 103.5 and she was still shaking until about 12:45, where her temperature rose to an even 104, temperature stayed in the 101/102 range, had a low-grade fever 99/100 until about 4:30, when temperature jumped up to 103.5 again was recovering at the time of reporting. No follow up attempts are needed. No further information is expected.

Other Meds: NUVARING

Current Illness:

ID: 1673944
Sex: F
Age:
State: GA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Swollen Lymph nodes under left arm; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient medical history included asthma. The patient previously received acetylsalicylic acid (ASPRIN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced swollen lymph nodes under left arm. Therapeutic measures were not taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen Lymph nodes under left arm was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673945
Sex: F
Age:
State: GA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Fever; Chills; Whole body aches; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 09:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lamotrigine (MANUFACTURER UNKNOWN) and vortioxetine hydrobromide (TRINTELLIX); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 09:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 23:00, the patient experienced fever, chills, whole body aches and headaches which were most intense from 23:00-5:00 and symptoms continued through following day decreasing slightly. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, whole body aches and headaches was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LAMOTRIGINE; TRINTELLIX

Current Illness:

ID: 1673946
Sex: F
Age:
State: NJ

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Very bad random itching; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, allergy to penicillin and sulfonamide. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (VITAMIN D) and calcium supplement (MANUFACTURER UNKNOWN) both for an unknown indications on unknown dates and unknown if ongoing. The patient previously received denosumab (PROLIA) for osteoporosis, last shot was in Nov2020. Also the patient previously received amoxicillin (MANUFACTURER UNKNOWN), mefenamic acid (ADVIL), ibuprofen (MOTRIN) and naproxen sodium (ALEVE) all for an unknown indications on an unknown dates and experienced drug allergy. On 05Apr2021 at 15:00, the patient experienced very bad random itching without rash, like someone was poking randomly around her body (eye lid, scalp, thigh, arm, etc), with a pin, while it did not hurt but was itchy, the patient constantly wanted to scratch those different places. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of adverse event which included treatment with ALLEGRA. The clinical outcome of the event very bad random itching was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; CALCIUM

Current Illness:

ID: 1673947
Sex: M
Age:
State:

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210201; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Chills; Fever; Sore arm; Weakness; Dizziness; Body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 17Apr2021 at 09:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 23:45, the patient experienced chills, fever, sore arm, weakness, dizziness and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 01Feb2021, the patient underwent Nasal Swab and the result was negative. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, sore arm, weakness, dizziness and body aches was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673948
Sex: F
Age:
State: ID

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Head pain on left side encompassing cheekbone and reaching all the way back behind left ear and up to crown of head. Head pain has gotten worse over the last 24 hours.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 14:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cefalexin (CEPHALEXIN) and sulfamethoxazole, trimethoprim (BACTRIM) taken for an unknown indication, from an unknown date and unknown if ongoing. On 17Apr2021 at 15:30, the patient experienced head pain on left side encompassing cheekbone and reaching all the way back behind left ear and up to crown of head. Head pain had gotten worse over the last 24 hours. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event head pain on left side encompassing cheekbone and reaching all the way back behind left ear and up to crown of head was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CEPHALEXIN [CEFALEXIN]; BACTRIM

Current Illness:

ID: 1673949
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Menstrual cycle 15 days later; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 14Apr2021 at 12:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. The patient's menstrual cycle started on 04Apr2021, her cycle was regular for every 24 to 28 days. On 19Apr2021 at 10:00, the patient got her menstrual cycle 15 days later, that was not normal. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle 15 days later was unknown at the time of this report. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673950
Sex: F
Age:
State: MI

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Measles like rash on face the morning after both doses; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Mar2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Apr2021 at 12:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 08:00, the patient experienced measles like rash on face the morning after both doses. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event measles like rash on face was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673951
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Swelling lymph node in one of breasts with the size as Lima bean; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced swelling lymph node in one of the breasts with the size as lima bean. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling lymph node in one of the breasts with the size as lima bean was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673952
Sex: M
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/12/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Small red bumpy rash on mid on back; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 12Apr2021 at 13:00, the patient experienced small red bumpy rash on mid on back. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event small red bumpy rash on mid on back was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673953
Sex: F
Age:
State:

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210420; Test Name: Body temperature; Result Unstructured Data: Test Result:103; Comments: Fever of 103

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: fever of 103; chills; lung discomfort; shooting pain down nerves; migraine; nausea; dizziness; soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 the patient experienced fever of 103 (unspecified unit), chills, shooting pain down nerves, lung discomfort, migraine, soreness, nausea and dizziness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. On 20Apr2021 the patient checked her body temperature and it was 103(unspecified units). Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 103(unspecified units), chills, shooting pain down nerves, lung discomfort, migraine, soreness, nausea and dizziness were recovered with sequelae on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673954
Sex: F
Age:
State:

Vax Date: 03/04/2021
Onset Date: 03/06/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: shortness of breath; Itching; swelling under the eyes; red blotchy skin; This is a spontaneous report from a contactable consumer (patient). A 66-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6203, expiration date was not reported), via an unspecified route of administration, administered in left arm on 04Mar2021 07:15 (at the age of 66-years-old) as dose 1, single for covid-19 immunization. The patient medical history included allergy to sulfa drugs, food allergy to chocolate. Concomitant medications were not reported. No other vaccine received in four weeks. No other medications received in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that, on 06Mar2021: 06:00 AM the patient experienced Itching, swelling under the eyes, red blotchy skin, shortness of breath. These are the same side effects when I take sulfa drugs. Patient took benadryl and used cortisone cream as treatment for adverse event. Therapeutic measures were taken as a result of shortness of breath, itching, swelling under the eyes, red blotchy skin. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673955
Sex: F
Age:
State: AZ

Vax Date: 04/14/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: I was getting head ache with one side most of the time left side.; On my left leg 1 inch red and pinkish rash came with out pain.; Feeling like my eyes power changed. I was not able to see like before vaccination; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 18:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as unknown. It was unknown whether the patient was pregnant at the time of vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. It was unknown whether the patient had allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, five days after the vaccination the patient experienced head ache with one side most of the time left side. The patient developed one inch red and pinkish rash on the left leg came without pain. Felt like eyes power changed. The patient was not able to see like before vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, one inch red and pinkish rash on the left leg, felt like eyes power changed, was not able to see like before vaccination were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673956
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Numbness and tingling on left side of lips and left cheek; Numbness and tingling on left side of lips and left cheek; Numbness and tingling on left side of lips and left cheek; Numbness and tingling on left side of lips and left cheek; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 23:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included epstein-barr, melanoma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received ciprofloxacin (CIPRO) on an unknown date for unknown indication and experienced drug allergy. On an unknown date in 2021, the patient experienced numbness and tingling on left side of lips and left cheek which lasted for 10 minutes. The events resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness and tingling on left side of lips and left cheek were resolved on an unknown date in 2021, after the duration of 10 minutes. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673957
Sex: F
Age:
State: GA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Injection site area larger; injection site itching; Large red raised area around injection site; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 21Apr2021 at 09:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient received other vaccine within four weeks prior to the COVID vaccine. Patient received varicella zoster vaccine rgE (CHO) (SHINGRIX) on 09Mar2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 24Mar2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 07:00, the patient experienced large red raised area around injection site, appeared two days after shot and on day 3, 23Apr2021, area was larger and itchy. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event large red raised area around injection site, appeared two days after shot and on day 3, 23Apr2021, area was larger and itchy was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673958
Sex: F
Age:
State: NC

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 12:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS), immunocompromised, type 2 diabetes mellitus, gastroparesis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient previously took ciprofloxacin (CIPRO) for an unknown indication on an unknown date and experienced drug allergy. On 21Apr2021 at 04:00, the patient experienced a very sore arm. On 22Apr2021, two days later, the patient was covered in a hot, red rash on body, whole stomach and chest, arms, legs, back, buttocks. The vaccine site was red and swollen to the size of a softball. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events a very sore arm, covered in a hot, red rash on body, whole stomach and chest, arms, legs, back, buttocks, vaccine site was red and swollen to the size of a softball was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673959
Sex: F
Age:
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210422; Test Name: Body Temperature; Result Unstructured Data: Test Result:102.6 Units:{DF}; Comments: Fever 102.6

Allergies:

Symptom List: Nausea

Symptoms: Fever 102.6; Nausea; Vomiting; Body aches; Headache; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the right arm on 21Apr2021 at 14:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other unspecified vaccine within four weeks prior to the vaccination on 01Apr2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 04:30, the patient experienced fever 102.6, nausea, vomiting, body aches, headache and feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever 102.6, nausea, vomiting, body aches, headache and feeling unwell were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673960
Sex: F
Age:
State: MI

Vax Date: 04/01/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Cold.; Clammy; Feeling like fever/ but no measurable fever; This is a spontaneous report from a contactable consumer, the parent. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergy to lots of foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included allergy shots (as reported) for unknown indication from an unknown start date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021, after 21 hours of vaccination, the patient experienced cold, clammy and feeling like fever, but no measurable fever. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events cold, clammy and feeling like fever but no measurable fever was unknown at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673961
Sex: M
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; achy upper body; sore upper legs; my skin was especially sensitive.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, at 07:00 the patient experienced headache, achy upper body, sore upper legs. The patient experienced upper body all felt sore and his skin was especially sensitive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, achy upper body, sore upper legs and skin sensitive were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673962
Sex: M
Age:
State: OH

Vax Date: 04/11/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Broke out in Hives / welts on arms, legs , lower back and rump; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 11Apr2021 at 14:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included small stroke in 2018. The patient had no known allergies to medications, food or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and sildenafil (MANUFACTURER UNKNOWN); both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 21Mar2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 22:00, the patient broke out in hives while sleeping, it continued nightly through 23Apr2021 with welts on arms, legs, lower back and rump that went away during the day and flared up while asleep. The patient reported that he had contacted his dermatologist. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the event hives with welts on arms, legs, lower back and rump were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; SILDENAFIL

Current Illness:

ID: 1673963
Sex: F
Age:
State:

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:{DF}

Allergies:

Symptom List: Tremor

Symptoms: 1st shot was fine, after 2nd shot had body aches, fever of 102, chills; 1st shot was fine, after 2nd shot had body aches, fever of 102, chills; 1st shot was fine, after 2nd shot had body aches, fever of 102, chills; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 17:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included escitalopram (MANUFACTURER UNKNOWN) and norethisterone (NORETHINDRONE); both from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation and was fine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. First shot, the patient was fine, after second shot, the patient had body aches, fever of 102 (units unspecified), chills on 22Apr2021. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events after second shot had body aches, fever of 102 (units unspecified), chills was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ESCITALOPRAM; NORETHINDRONE [NORETHISTERONE]

Current Illness:

ID: 1673964
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Pain in left leg and back; Pain in left leg and back; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. On 20Apr2021 at 13:00, the patient experienced pain in left leg and back. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and the patient would see a doctor on the day of report. The clinical outcome of the events pain in left leg and back were resolving at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673965
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: The patient experienced a migraine; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the next day after receiving the second dose of the vaccine the patient experienced a migraine. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19.The clinical outcome of the event migraine was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673966
Sex: F
Age:
State: MO

Vax Date: 04/01/2021
Onset Date: 04/03/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Shingles pain (mild to moderate) in the upper back and torso; Redness; shingles pain (mild to moderate) in theupper back and torso; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8730) via an unspecified route od administration on 01Apr2021 at 17:00 in the left arm (at the age of 52-years-old) as single dose for COVID-19 immunisation. Medical history included autoimmune NOS, shingles event April 2020 and environmental allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccination within 4 weeks prior to COVID vaccine. Concomitant medication included colecalciferol (VITAMIN D3), CENTRUM WOMEN and vitamin b complex (B-COMPLEX); all for unspecified indication and start date. On 03Apr2021, started with 48 hours post vaccine, the patient experienced shingles pain (mild to moderate) in the upper back and torso, redness and had no visible rash. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events with unspecified topical cream and otc acetaminophen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of shingles pain (mild to moderate) in the upper back and torso and redness were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; B-COMPLEX [VITAMIN B COMPLEX]

Current Illness:

ID: 1673967
Sex: F
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: eyes began itching in the middle of the night; woke up with red swollen eyes; woke up with red swollen eyes; swollen face; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 20Apr2021 at 14:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021, at 00:00 the patient experienced eyes began itching in the middle of the night. On 21Apr2021, the patient woke up with red swollen eyes and a swollen face. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes began itching in the middle of the night, red swollen eyes and swollen face were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673968
Sex: F
Age:
State: MI

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Moderate body pain; Fatigue; Mild headache; Low fever; Upset stomach; This is a spontaneous report from a contactable healthcare professional, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 20Apr2021 at 14:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy, depression, anxiety and pre-diabetes. The patient had unspecified allergies to medications, food, or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN), duloxetine hydrochloride (DULOXETINE DR), lisdexamfetamine mesilate (VYVANSE) and buspirone (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 06:30, the patient experienced moderate body pain, fatigue, mild headache, low fever and upset stomach. Therapeutic measures were taken as a result of the events and included treatment with Over-The-Counter (OTC) medication Aleve. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events moderate body pain, fatigue, mild headache, low fever and upset stomach were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; DULOXETINE DR; VYVANSE; BUSPIRONE

Current Illness:

ID: 1673969
Sex: F
Age:
State: TX

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Swollen fingers; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER873-) via an unspecified route of administration in the left arm on 19Apr2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 12:00 the patient experienced swollen fingers . The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen fingers was recovered on 20Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673970
Sex: M
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: Body temperature; Result Unstructured Data: Test Result:101.3; Comments: At 21:00

Allergies:

Symptom List: Pain in extremity

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO158) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:00, the patient experienced temperature of 101.3 (unit unspecified), fever including shakes, chills, vomiting, pain in the injection site, myalgia, inflamed lymph node behind the right ear, headache and fatigue. It was reported that these events lasted for 36 hours however, fatigue and inflamed lymph node behind the right ear were ongoing but the patient was generally healthy. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events temperature of 101.3/ fever, shakes, chills, vomiting, pain in the injection site, myalgia and headache was recovered on 23Apr2021 at 09:00 while outcome of the events inflamed lymph node behind the right ear and fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673971
Sex: M
Age:
State: OR

Vax Date: 04/18/2021
Onset Date: 04/20/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: lips began burning; lips swelling; Lips pain; Painful mouth; burning, swelling, and hurting a lot. Its spreading to the rest of my mouth.; swelling, and hurting a lot. Its spreading to the rest of my mouth.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 09:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and gluten allergy. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and metoclopramide (REGLAN) both were from unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) from 2005 and for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021, Tuesday morning at 08:00 the patient lips started burning, swelling, and hurting a lot. It was spreading to the rest of mouth and it was quite painful, although it was not anaphylaxis and definitely not life threatening. However, it continues to get slowly and steadily worse. The patient had severe celiacs disease, so the patient eats the same foods every day and never alter those meals, even down to the smallest ingredients. He was aware of everything that touches his skin. He was sorry to say but there really isn't anything else that could be causing this. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lips began burning, swelling, and hurting a lot mouth painful, mouth burning and mouth swelling were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1673972
Sex: M
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Ultrasounds; Result Unstructured Data: Test Result:Large nodes up to 3 cm; Test Date: 20210421; Test Name: Temperature; Result Unstructured Data: Test Result:Temperature over 100

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Lymph nodes under the left armpit grew enormously large, there is clearly an inflammation and it hurts a lot; Migraine; Temperature over 100; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 20Apr2021 at 12:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included an allergy to cats. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 30Mar2021 at 12:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 06:00, the patient experienced migraine, temperature over 100 and lymph nodes under the left armpit grew enormously large, there was clearly an inflammation and it hurt a lot. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. On 21Apr2021 at 06:00, the patient underwent test for body temperature and the result was fever with temperature over 100. On an unknown date in Apr2021, the patient underwent lab tests and procedures, which included ultrasounds exam and the result was several large nodes up to 3 cm. Therapeutic measures were taken as a result of events and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The clinical outcome for the events migraine, fever and swollen lymph nodes were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673973
Sex: F
Age:
State: NY

Vax Date: 04/13/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Large rash on right arm; Sore on right arm; Sore on right hand knuckle; Stunk when washed hands; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic reaction to bee sting. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified medications within two weeks of vaccination. On 22Apr2021 at 17:00, the patient experienced a sore on her right-hand knuckle, and it stunk when she washed her hands, Cleaned it out with peroxide. The patient went to bed at 23:00. On 23Apr2021 at 04:00, the patient woke up and went into the bathroom turned on the light and saw another sore on her right arm and large rash on her right arm. She went back to bed and woke up about 8:00 and rash had shrunk to half its size. It doesn't itch. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore on right hand knuckle, stunk when washed the hands, sore on right arm and large rash on right arm were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673974
Sex: F
Age:
State: TX

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Severe pain in lower back; Dizzy; Headache; Fever; Chills; Nauseous; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 08:45, the patient experienced headache, fever, chills, severe pain in lower back, dizzy and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, fever, chills, severe pain in lower back, dizzy and nauseous were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673975
Sex: F
Age:
State: IA

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Body aches; Joint pain; Vaccination site pain and soreness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. The patient previously took amoxicillin on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and allergy shots from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00 the patient experienced body aches and joint pain for 24 hours, injection site pain and soreness for 4days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, joint pain were recovered on15Apr2021. The clinical outcome of the event injection site pain and soreness was recovered on 17Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1673976
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Insomnia for several days; This is a spontaneous report from a non-contactable consumer. A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies which were unspecified. It was unknown if the patient was pregnant at the time vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On an unknown date, the patient experienced insomnia for several days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event insomnia for several days was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673977
Sex: M
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: still foggy; some short term memory issues; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the right arm on 24Mar2021 at 17:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure and allergy. Concomitant medications included unspecified medications for blood pressure and allergy, taken from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 18:45, the patient experienced foggy which was still present at the time of this report and had some short-term memory issues. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events foggy and short-term memory issues were resolved with sequelae on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673978
Sex: F
Age:
State: ID

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5 Units:{DF}; Comments: At 14:00

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Chills; Fever 100.5; "Intense fatigu"; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 21Apr2021 at 17:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included a known allergy to sulfa (sulfonamide) drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included progesterone (PROMETRIUM) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 22Apr2021 at 14:00, the patient experienced chills, fever 100.5 (unspecified units) and "intense fatigu". The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever 100.5 (unspecified units) and "intense fatigu" were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROMETRIUM [PROGESTERONE]

Current Illness:

ID: 1673979
Sex: F
Age:
State: WA

Vax Date: 02/20/2021
Onset Date: 03/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Debilitating pain mostly on the right side of body from hip to foot, inside of knees on both legs, left shin, front and back of left leg; Shooting pain is similar to sciatica; Pain caused to quit walking and doing exercises; Sometimes the pain wakes up at night; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 20Feb2021 at 10:00 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and iodine allergy (internal). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included hydrochlorothiazide/losartan potassium (MANUFACTURER UNKNOWN) "100'' for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an unspecified route of administration in the left arm on 24Jan2021 at 10:00 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. The patient previously received oxycodone/aspirin (PERCODAN), lorsartan potassium (MANUFACTURER UNKNOWN), ketotifen fumarate (ZADITOR EYE DROPS) and amlodipine (MANUFACTURER UNKNOWN) and experienced drug allergy. On an unknown date in Mar2021, the patient experienced debilitating pain mostly on the right side of body from hip to foot, inside of knees on both legs, left shin, front and back of left leg. Sometimes, shooting pain was similar to sciatica which caused to quit walking and doing exercises. Walking up and down stairs was painful and it bothered the patient mostly at night when lying in bed. Sometimes, the pain woke her up at night. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result adverse events and included unspecified treatment which was ongoing. The clinical outcome of the events debilitating pain mostly on the right side of body from hip to foot, inside of knees on both legs, left shin, front and back of left leg, shooting pain was similar to sciatica and pain caused to quit walking and doing exercises and sometimes the pain wakes her up at night were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE;LOSARTAN POTASSIUM

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am